Abstract
A comparison of the prognostic values of the Dukes and Jass systems were performed with 722 patients with rectal cancer enrolled in the National Surgical Adjuvant Breast and Bowel Projects, protocol R-01. The Jass system revealed four prognostic groups when all patients or only Dukes' B and C cases were examined; however, the magnitude of differences between groups I and II and III and IV were small. Dukes' classification, as defined in this study, revealed five prognostic groups. A statistically strong association between the Jass and Dukes systems was observed. Although histologic grade permitted further prognostic discrimination of all Dukes stages except A, only the Jass system allowed for the subdivision of C cases with up to four nodes positive for metastases. Those in that group had survival rates comparable to B cases (no nodal involvement) when scores of I and II were found. The distributions of the patients in the extremes of the Jass and Dukes systems (C2 as defined) were almost similar. The findings indicate that the Jass system is a valid prognostic method for patients with rectal carcinoma. In this material, however, it basically allowed for only two major prognostic groups whereas five were noted by the Dukes method. These results, as well as the more objective nature of Dukes' classification, warrant its continued use for prognosis and therapeutic decisions for patients with rectal cancer.
Similar content being viewed by others
References
Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987;1:1303–6.
Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from SNABP protocol R-01. JNCI 1988;8:21–9.
Dukes CE. The surgical pathology of rectal cancer. J Clin Pathol 1949;2:95–9.
Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 1967;166:420–7.
Gabriel WB, Dukes CE, Bussey HJ. Lymphatic spread in cancer of the rectum. Br J Surg 1935;23:395–413.
Fisher E, Redmond C, Fisher B. Pathologic findings from the national surgical adjuvant breast project (protocol no 4): discriminates for five-year treatment failure. Cancer 1980;46:908–18.
Cutler S, Ederer F. Maximization of the life table method in analyzing survival. J Chronic Dis 1958;8:699–712.
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163–70.
Cox DR. Regression model and life tables. J R Stat Soc (B) 1972;34:187–220.
Author information
Authors and Affiliations
Consortia
Additional information
See Appendix.
This investigation was supported by Public Health Service Grants from the National Cancer Institute (NCI-U10-A-34212) and by a grant from the American Cancer Society (ACR-RC-13).
About this article
Cite this article
Fisher, E.R., Robinsky, B., Sass, R. et al. Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Dis Colon Rectum 32, 944–949 (1989). https://doi.org/10.1007/BF02552270
Issue Date:
DOI: https://doi.org/10.1007/BF02552270